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The exploration of the relationship between gene expression profiles and neural response 
patterns known to be altered in major depressive disorder provides a unique opportunity to 
identify novel targets for diagnosis and therapy. Here, we estimated the spatial association 
between genome-wide transcriptome maps and brain activation patterns from functional 
magnetic resonance imaging (fMRI) with two established paradigms of great relevance for 
mood disorders. While task-specific neural responses during emotion processing were 
primarily associated with expression patterns of genes involved in cellular transport, reward 
processing was related to neuronal development, synapse regulation, as well as gene 
transcription. Multimodal integration of single-site and meta-analytic imaging data with risk 
genes associated with depression revealed a regional susceptibility of functional activity, 
modulated by master regulators TCF4 and MEF2C. The identification of multiple subordinate 
genes correlated with fMRI maps and their corresponding regulators presumably will reshape 
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Over the last decades, genetic and neuroimaging studies have significantly contributed to 
current knowledge about human neural functions. While single neuroscientific methods 
contributed to the comprehension of physiological processes as well as pathological 
alterations in psychiatric disorders, a multimodal integration of large-scale data has proven to 
be even more conducive for in-depth understanding, especially on the molecular scale. In 
particular, post-mortem gene expression data from the Allen Human Brain Atlas (AHBA) was 
repeatedly applied to investigate the relationship between the transcriptome and protein 
distribution (1), brain connectivity (2), or morphology (3). These studies add up to numerous 
wide-ranging research findings combining mRNA expression with neuroimaging parameters, 
partially offering toolboxes for an integrative data analysis (4). Different methods offer 
designated benefits and disadvantages, e.g. the precise temporal resolution of 
electroencephalography contrasts to its low spatial resolution. In case of positron emission 
tomography, molecular specificity allows quantification of protein distributions in vivo, but 
availability of specific radioligands is limited. In general, indirectly measuring brain 
activation during execution of specific paradigms by means of functional magnetic resonance 
imaging (fMRI) has evolved into one of the most popular neuroimaging techniques. Although 
a promising approach to contrast topological brain activation and gene expression patterns 
making use of the meta-analytic Neurosynth database was presented by Fox and colleagues 
(5), their study lacked disease-related aspects. Other studies, by contrast, have successfully 
integrated post-mortem data and in vivo imaging findings, to assess the influence of regional 
gene expression on psychiatric disorders (6). While fMRI can depict neural correlates of 
specific psychological processes with high spatial resolution, measured signal patterns also 
appear susceptible to genotype variations (7). However, the role of specific master regulators 
(MRs) modulating differentially expressed genes that might influence regional blood 
oxygenation level dependent (BOLD) signaling has not been resolved yet. 
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From all psychiatric disorders, major depressive disorder (MDD) is now the leading cause of 
disability worldwide and a strong contributor to the overall global burden of disease, with 
increasing prevalence over the years (8). Granted that additive genetic effects attribute to 
approximately 9 % of the variation in liability of MDD (9), regional variations in gene 
expression profiles may determine brain function within a continuum, spanning from a 
physiological to a more critical pathological state. In this regard, paradigms examining core 
depressive symptoms like impaired affect modulation or loss of interest and pleasure in 
common experiences are amongst the best-established within the realms of MDD. Further, 
alterations of BOLD reactivity during processing of negatively valenced information as well 
as motivation- or incentive-based learning emphasize the characterization of neuropsychiatric 
disorders in terms of functions rather than diagnoses (10, 11). Positive valence systems and 
systems for social processes thereby comprise prominent behavioral elements and justify the 
application of emotion and reward processing paradigms to investigate major domains of 
human functioning that are currently part of the Research Domain Criteria (RDoC) 
framework. 
In this study, genes with expression patterns correlated with task-specific brain activation 
were evaluated in regard to biological processes according to the Gene Ontology (GO) 
database (12) as well as their relationship with risk genes for MDD obtained from 
conventional Genome-wide association studies (GWAS) (9). Potential influences of master 
regulating genes on neuroimaging parameters were evaluated and initial results based on 
single-site fMRI data subsequently replicated applying meta-analytic activation maps from 
the Neurosynth online framework (13). Ultimately, we aimed to identify individual MRs 
modulating topological mRNA expression that was associated with brain activation during 
emotion and reward processing.  
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Topological specificity of emotion and reward processing 
In conjunction with known abnormalities in social interaction and reward responsiveness of 
patients with depressive disorders, fMRI activation within the social processes and positive 
valence systems domains of the RDoC framework was evaluated. We minimized unspecific 
signal variations related to visual, auditory, attentional and executive processing by 
contrasting brain activation elicited by the experimental condition with task control conditions 
in each participant. Sequentially, second level analyses provided topological activation 
elicited by emotion and reward processing (full acquisition and analysis pipeline described in 
Material and Methods section). The applied emotional face recognition task didn’t focus 
attention on the emotional content of presented faces, but requested gender discrimination 
instead, provoking rather implicit emotional processing in limbic as well as non-limbic areas 
such as prefrontal cortices. When testing reward responsiveness, significant activations in 
dopaminergic brain regions were observed after acceptance of priorly conditioned stimuli, 
particularly in the mesolimbic reward system (table S1). 
To expand the scope of results generated with single-site data, we obtained corresponding 
uniformity maps from the Neurosynth database for complementary analyses. Detected brain 
activation clusters were thereby replicated using matching data derived from 91 and 246 
studies associated with the terms “fearful faces” and “rewards”, respectively. Both meta-
analytic maps were in conformity with measured imaging data and can be obtained online 
from the Neurosynth framework.  
 
Associations between transcriptome maps and functional brain activation 
For each paradigm, subsequent correlation analyses showed marked associations between 
functional brain activation and mRNA expression for a large number of individual genes 
(rankings of genes as well as corresponding Spearman’s correlation coefficients for both 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted June 27, 2020. . https://doi.org/10.1101/2020.06.27.175257doi: bioRxiv preprint 
6 
 
datasets are reported in table S2). Due to marked gene expression differences, correlations 
were performed and ranked separately in cortical and subcortical regions. Findings were 
highly specific for each paradigm, accounted for by the weak overlap of compiled correlation 
lists between emotion and reward processing (subcortex: rhoRRHO = - 0.282; cortex: rhoRRHO = 
0.205) (fig. S1). In contrast, high agreement of ranked mRNA-fMRI correlations between two 
different brain parcellation atlases was observed both for emotional face recognition 
(subcortex: rhoRRHO = 0.697; cortex: rhoRRHO = 0.822) and acceptance of monetary rewards 
(subcortex: rhoRRHO = 0.748; cortex: rhoRRHO = 0.918) (fig. 1).  
 
Regarding single-site data, functional brain activity evoked by emotion processing correlated 
positively as well as negatively with whole-brain transcriptome maps. Region-wise 
correlations yielded similar results compared to voxel-wise analyses, ranging from rho = 
-0.739 to rho = 0.865 for subcortical and from rho = -0.449 to rho = 0.431 for cortical regions 
(fig. S2, A and B). Out of all resulting associations between gene expression and brain 
function the 10 highest positive correlating genes are listed in table 1. In subcortical regions, 
MALL showed the strongest voxel-wise correlation (rho = 0.633), while C10orf125 showed 
the highest region-wise correlation (rho = 0.865). In the cortex, SPDYA yielded strongest 
voxel-wise (rho = 0.328) and FOXN4 strongest region-wise (rho = 0.431) correlation. 
FOXN4 also showed a high cortical ranking applying voxel-wise analysis (rho = 0.285, 5th 
rank) (fig. 2, A and B).  
 
Analogous to the emotion task, compiled ranked lists included genes strongly correlated with 
measured functional brain activity related to the reward system, whereby the 10 highest 
positive correlating genes are listed in table 2. Region-wise analyses yielded higher 
correlation coefficients than the voxel-wise approach with less prominent associations in the 
cortex (rho = -0.639 to rho = 0.698), compared to subcortical regions (rho = -0.788 to rho = 
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0.81). In the subcortex, MDK showed the strongest voxel-wise correlation of all genes (rho = 
0.488) and also a high region-wise correlation coefficient (rho = 0.803, 3rd rank) (fig. 2, C and 
D). Comparing strongest voxel-wise vs. region-wise correlations in the cortex, 7 out of 10 
genes were congruent (DUSP3, CA10, PIK3CD, HDAC9, LASS6, GRB14, OLFM3), 
indicating high agreement between both approaches (fig. S3, A and B). Thereby, gene 
expression of DUSP3 showed strongest cortical correlations with reward processing both in 
the voxel-wise (rho = 0.548) as well as the region-wise analysis (rho = 0.698) (fig. S4).  
 
Ontological analysis of task-specific biological processes 
Considering both strong positive and negative mRNA-fMRI correlations, multiple genes 
associated with imaging data overlapped with specific gene sets listed in the GO 
knowledgebase (presented in detail in table S3 and fig. S5, A to C). Notably, a marked 
redundancy between GO terms was present within each paradigm, indicating rather task-
specific associations of molecular programs with gene expression patterns throughout the 
human brain (fig. 3). Considering neural responses during emotional face recognition in 
subcortical regions, significantly associated biological programs were related to cellular 
transport processes and mainly included genes that showed positive correlations between gene 
expression and imaging data. In line with the assumed relevance of molecular transduction for 
emotion regulation processes, the most significant overlap was observed for the GO term 
peptide transport. In total, 203 genes positively correlated with emotion processing were also 
present within this gene set (pcorr = 0.013), representing 7.9 % of genes included within the 
GO term (GO:0015833). Functional brain activation in cortical regions yielded no significant 
overlap with biological processes. Analyzing neural responses during acceptance of monetary 
rewards in subcortical regions, associated GO terms mainly included genes with positive 
mRNA-fMRI correlations, predominantly comprising transcription processes. Highest 
significance was present for nucleic acid metabolic process (GO:0090304, pcorr < 0.001, 536 
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genes, 8.95 %), RNA metabolic process (GO:0016070, pcorr < 0.001, 486 genes, 8.89 %), as 
well as cellular macromolecule biosynthetic process (GO:0034645, pcorr < 0.001, 485 genes, 
8.45 %). GO terms associated with genes negatively correlated with the acceptance of 
monetary rewards within subcortical regions mainly related to synaptic processes and 
neuronal development. Thereby, most significant GO terms were chemical synaptic 
transmission (GO:0007268, pcorr < 0.001, 54 genes, representing 6.19 % of genes included 
within this term) and modulation of chemical synaptic transmission (GO:0050804, pcorr < 
0.001, 35 genes, 6.4 %). However, in the cortex only two overlapping GO terms were found 
for genes positively associated with reward processing (autophagy of mitochondrion, 
GO:0000422, pcorr < 0.05, 4 genes, 3.96 % and sensory perception of sound, GO:0007605, 
pcorr = 0.04, 4 genes, 2.34 %). 
 
The role of risk genes associated with major depression 
The relationship between single-site neuronal brain activation and 42 functional genes 
associated with MDD obtained from a pre-defined gene set was investigated to evaluate the 
superordinate role of these risk genes on measured BOLD activation patterns. Master 
regulator analysis of co-regulatory networks based on previously compiled ranked lists 
including strongest mRNA-fMRI correlations and revealed individual candidate MRs for each 
paradigm that potentially regulate genes positively and negatively associated with imaging 
data. We found 4 regulators from the MDD risk gene set for emotion and 3 for reward 
processing in subcortical regions, with 79 and 89 possible targets, respectively (p < 0.001) 
(table 3). Curiously, PAX6, LHX2, as well as MEF2C were associated with negatively 
correlated genes for both paradigms, indicating a rather superordinate role of these MRs in 
MDD, regardless of cognitive system. Alternatively, TCF4 was identified both as a regulator 
for genes negatively correlated with emotion as well as genes positively correlated with 
reward processing. Overall, strongest regulation was found for genes negatively correlated 
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with reward processing, whereby LHX2 and MEF2C coordinated more than half of the 
possible targets. Considering regulation for genes that showed positive correlations with 
functional brain activation, two MRs (SOX5 and TCF4) were identified for reward 
processing, while no significant regulators were found for genes positively correlated with 
emotion processing. Subcortical single-site results were replicated when applying independent 
meta-analytical data from the Neurosynth framework. Identically, MEF2C emerged as 
regulator of genes negatively correlated with emotional face recognition as well as acceptance 
of monetary rewards (fig. 4A), while TCF4 showed an inversed regulation of genes correlated 
with the emotion (negative association) and reward (positive association) paradigm (fig. 4B).  
Single-site and meta-analytical findings from gene set enrichment analysis (GSEA) 
complemented results from GO as well as master regulator analyses, showing an inversed 
aggregation of MDD risk genes for emotion and reward processing. Rather than focusing 
solely on ranks of single genes, by means of GSEA we could assess the role of the whole 
gene set associated with depressive disorders. Regarding emotion processing, risk genes were 
predominantly enriched within positively correlated genes, while location of the maximum 
enrichment score (ES) for reward processing emphasized genes showing negative correlations 
with imaging parameters in both data sets, albeit not reaching statistical significance. Within 
the Neurosynth replication sample, the maximum subcortical ES yielded 0.275 (p = 0.051) for 
emotion and -0.243 for reward processing (p = 0.65), respectively (fig. 4C). In the cortex, the 
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Here, we applied a comprehensive and integrative methodological approach to investigate the 
relationship between regional gene expression patterns and macroscopic BOLD responses 
elicited by emotional face recognition and the acceptance of monetary rewards, under the 
assumption that strongly correlated genes would coincide with distinct biological programs 
and genes implicated in depressive disorders. Unbiased screening for novel associations 
between mRNA expression and functional brain activation resulted in ranked lists of 18,686 
genes positively and negatively correlated with BOLD signaling. Similar distributions of 
Spearman’s correlation coefficients were present for emotion (ranging from rho = -0.739 to 
rho = 0.865 in subcortical and from rho = -0.449 to rho = 0.431 in cortical areas) and reward 
processing (from rho = -0.788 to rho = 0.81 in the subcortex and from rho = -0.639 to rho = 
0.698 in the cortex). Considering strongest brain activation elicited by emotion processing in 
ventral striatum, amygdala, ventral tegmental area, fusiform gyri, insula and medial prefrontal 
cortex, in that order, it seems plausible that higher correlation levels were observed in 
subcortical regions, compared to the cortex. Exploring the GO knowledgebase, we detected 
task-specific processes related to cellular transport as well as neuronal development, synapse 
regulation, and transcription for emotion and reward processing, respectively. Notably, 
associated ontologies were interrelated solely within each fMRI paradigm, thus indicating 
unique biological programs for both investigated RDoC domains. Focusing on systems for 
social processes and positive valence systems, the meta-analytic replication sample comprised 
of activation maps from over 90 fMRI studies. Based on correlations between imaging 
parameters and gene expression, we identified master regulators associated with depressive 
disorders and task-specific functional brain activation, TCF4 and MEF2C, in two independent 
datasets. While MEF2C showed a congruent regulation with negative associations related to 
emotion and reward processing, TCF4 appeared simultaneously as a regulator for genes 
negatively correlated with the emotion task, but positively correlated with reward processing. 
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Albeit not reaching statistical significance, the supplementary GSEA suggested an inversed 
distribution of the risk gene set for major depression, showing a rather positive association 
with imaging data for emotional face recognition and a negative association for the 
acceptance of monetary rewards. 
 
Although the role of gene expression patterns has been reviewed for several fMRI measures 
(2, 3), individual genetic influences on emotional face recognition or adaptive reward-based 
decision-making have only been evaluated for the presence of single gene variants of 
functional proteins (i.e. CREB1), irrespective of topological distribution (7). Particularly in 
MDD, additive genetic effects may attribute to individual differences in the phenotype and 
highlight the importance of large-scale data in systems medicine to resolve unsettled genetic 
influences on neuroimaging paradigms. While over 322 million people worldwide suffer from 
depressive disorders, a number that increased by 18.4 % between 2005 and 2015 (8), a 
significant part of the population is also affected by subthreshold depressive symptoms, 
potentially originating from different levels of genetic susceptibility in relevant neuronal 
systems. Our findings strongly support the idea of a dimensional genetic background 
influencing activated brain regions within emotion and reward systems that continuously 
progresses from physiological to pathological states, recently highlighted within the much-
noticed RDoC framework (11). In line with the debilitating symptoms of depressive disorders, 
we investigated paradigms reflecting principal functions of both the reward responsiveness 
construct within the positive valence systems domain as well as the social communication 
construct, which is part of the systems for social processes domain. Hyper- as well as 
hypoactivations of brain regions involved in the integration of social information, reduced 
reward sensitivity and decision-making efficiency suggest a polygenic nature of depressive 
disorders with distinct imaging features (14). However, identifying the core set of risk genes 
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is complicated due to widespread and disease-specific network interactions as well as 
modulatory MRs.  
 
In this study, regulating genes associated with MDD included protein coding MEF2C 
(Myocyte Enhancer Factor 2C), which plays a role in neuronal development, as well as 
hippocampus-dependent learning and memory (15). Relevance for synapse regulation arises 
due to alternatively spliced transcript variants involved in neuronal processes, e.g. activated 
TLR4 signaling or the cAMP response element-binding protein (CREB) pathway. Besides 
depressive disorders, associations of this transcription activator with other psychiatric 
disorders like schizophrenia (16) or attention-deficit/hyperactivity disorder (17) have been 
reported. Most notably, significant dependence of striatal neuronal activation was described 
for an identified risk variant in the TMEM161B-MEF2C gene cluster during a reward task, 
endorsing well-known deficits of reward processing in MDD, observed as anhedonia (18). 
Besides, we affirm previously reported relationships between neuropsychiatric disorders and 
mutations of TCF4, which has been implicated not only in depression, but also in 
schizophrenia and autism (19, 20). The transcription factor is mainly characterized by its 
regulatory role for the proliferation and differentiation of neuronal and glial progenitor cells. 
Interestingly, the master regulatory role of TCF4 in schizophrenia was recently endorsed by 
Torshizi et al., based on the analysis of transcriptional networks in two independent datasets 
(21). 
Since gene variants exhibit their effects by uncountable molecular mechanisms, a closer 
investigation of genes strongly associated with imaging parameters, as well as the MRs 
reported in this study, will prospectively allow further statements about regional protein 
biosynthesis and allocation of resulting proteins to cellular compartments. For example, 
DNA-binding transcription factor FOXN4 (Forkhead Box N4), belonging to the Forkhead-
box (FOX) superfamily, showed highest correlation with the emotional face recognition 
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paradigm in the cortex. FOX transcription factors are involved in regulatory biological 
processes and mutations in forkhead genes have been linked to developmental disorders in 
humans due to substitutions or frameshifts that disable or remove the DNA binding domain. 
The subtype FOXN4 thereby expresses developmental functions in neural and non-neural 
tissues, particularly during spinal neurogenesis by modulating a specific expression mosaic of 
other proneural factors. Further relevance for neural development was shown by Chen et al. 
(22), who demonstrated location of FOXN4 on neurons and astrocytes, as well as an increased 
expression after spinal cord injury lesions. Although associations with depressive or other 
neuropsychiatric disorders have not been published, the modulatory role of FOXN4 as a key 
transcriptional regulator during developmental processes demands further research, especially 
since the full set of its targets in the CNS are not known yet. Accordingly, the C10orf125 
gene (Fucose Mutarotase, FUOM), expressed in the brain and other tissues, showed highest 
correlation with emotional face recognition in the subcortex. The corresponding gene 
transcript, fucose mutarotase, is an enzyme of the fucose-utilization pathway performing the 
interconversion between α-L-fucose and β-L-fucose on human cell surfaces. Hereof, besides 
one animal study demonstrating male-like sexual behavior in FUOM knock-out mice, 
presumably resulting from reduced fucosylation during neurodevelopment (23), further 
associations with pathological states in mammals have not been published for this gene. 
Regarding reward processing, the protein coding DUSP3 (Dual-specificity phosphatase 3) 
gene, member of the dual-specificity protein phosphatase subfamily, showed strongest 
correlation with measured fMRI data in the cortex. Members of these protein tyrosine 
phosphatases (PTPs) regulate the phosphorylation of the mitogen-activated protein (MAP) 
kinase signaling pathway and control cell signaling, especially in regard to cytoskeleton 
reorganization, apoptosis and RNA metabolism. DUSP3 shows a wide expression in different 
tissues as an opposing factor of protein tyrosine kinases (PTKs) and acts as a central mediator 
of cellular proliferation and differentiation. Whereas a role in neoplastic disorders, 
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pathologies related to immunology, angiogenesis as well as Parkinson’s disease have been 
related to anomalous tyrosine phosphorylation (24), associations with psychiatric disorders 
have not been described. In subcortical regions, MDK (midkine) was among the highest 
correlating genes for the reward paradigm. MDK transcribes one of two growth factors from 
the heparin-binding cytokine family and plays a role during the differentiation of neurons. An 
important role of this gene has been suggested within dopaminergic pathways, particularly 
facilitating neuroprotective effects in neurodegenerative disorders, drug-induced neurotoxicity 
in the striatum, or after neural injury (25). Further, a disease-related publication suggests an 
influence of midkine on addictive behaviors (26), and more recently, associations of elevated 
serum levels of the neurotrophic factor have been found in autism spectrum disorder (27). 
 
Despite advances and decreased costs of high-throughput gene expression profiling the 
necessity for large cohorts in genetic studies call for collaborations and integrative 
approaches. By including whole-brain expression patterns, our approach can be discriminated 
from previous neuroimaging studies solely investigating global effects of disease-related 
SNPs or environmental factors. Still, a range of influencing factors hampers interpretation of 
spatial associations between gene expression and functional imaging data, like outdated 
annotation information, inaccurate sample assignment, or presence of locally correlated 
genes. Further, ubiquitous noise due to expression of genes with a low spatial dependence 
occurs, which has also been addressed by Gryglewski et al. (28). We performed all correlation 
analyses separately for cortical and subcortical regions, to prevent a possible bias that might 
arise from expression differences of the transcriptome between these brain areas. While 
mRNA levels don’t necessarily reflect actual in vivo protein densities, signal alterations in 
fMRI studies are also impaired by confounding variables, such as network-architectures, 
structural and functional connectivity measures, or non-specific brain activation. To minimize 
BOLD signaling elicited by superimposed executive functions, control conditions were 
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implemented for each task, facilitating specificity of performed correlations for both 
paradigms. Noteworthy, meta-analytic brain activation maps eventually confirmed findings 
from single-site fMRI measurements. In contrast to a previous study (5) that identified gene-
cognition associations based on the Neurosynth framework, we also increased spatial 
resolution and advanced probe selection of gene expression data by application of interpolated 
mRNA maps with continuous expression estimates throughout the whole brain. Surely, results 
of this study are limited due to the structure of applied data sets and reflect rather subtle 
genetic influences on psychological processes, disregarding the dynamic nature of short-term 
regulatory mechanisms or individual variations due to genetic ancestry and environmental 
factors. Inter-individual differences regarding effects of sex, age or genotype cannot be 
considered, when performing integrative analyses on the basis of the AHBA that originally 
derived expression values from only 6 post-mortem brains (29). Also, predictions of in vivo 
gene expression are limited due to locally and functionally regulated epigenetic and 
epitranscriptomic modifications that affect actual protein distribution (30). Nonetheless, the 
AHBA still offers the most comprehensive database for the investigation of human whole-
brain gene expression, comprising nearly 20,000 genes. Although a whole-brain proteome 
atlas including relevant genotypes would reflect actual protein expression more reliably, such 
database has not been published yet. Within the framework of future studies, the vast potential 
of the AHBA might even be increased by re-assigning available mRNA probes to 
corresponding genes on the basis of the latest sequencing information to increase the number 
of specifically annotated genes. Additionally, harmonized data processing pipelines and 
methodological guidelines, instead of rather unique approaches to data integration and 
corresponding statistical measures, could increase comparability between studies (31). 
 
Since explanations of altered fMRI activations often neglect the spatial distribution of 
investigated genetic substrates, evaluating the role of gene expression in neuropsychiatric 
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disorders requires an integration of high-resolution neural information from molecular sources 
for more precise interventions in the future. Our analyses highlight the advantages of a 
comprehensive approach to reveal genetic influences on functional brain imaging parameters 
by integrating multimodal imaging and large-scale genetic data with sufficient power. While 
insignificant results of GSEA were partly caused by the small number of analyzed risk genes, 
the low enrichment of the gene set associated with MDD might also be determined by a 
significant impact of individual MRs that modulate up- and downregulation of multiple 
subordinate genes, including risk and non-risk genes. In general, the GWAS performed by 
Wray and colleagues (9) is among the largest ever conducted in psychiatric genetics and 
provides a solid basis for further research about the genetic architecture of MDD. In this 
study, we successfully applied this GWAS data to explore imaging paradigms that 
specifically integrate core depressive symptoms in line with current RDoC, like dysfunction 
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While traditional strategies have solely investigated variations of individual genes without 
topological allocation, whole-transcriptome expression profiles provide superior information 
for the understanding of neuropsychiatric disorders. Here, biological programs related to 
cellular transport, neuronal development, synapse regulation, and transcription processes were 
specifically associated with two paradigms, highlighting the relationship between gene 
expression and in-vivo imaging parameters for both the emotion and reward system. Further, 
identification of regulatory genes TCF4 and MEF2C endorses the investigation of commonly 
altered brain activation during emotional face recognition and the acceptance of monetary 
rewards in depressed individuals. Overall, our work exemplifies an integrative approach 
including complementary information from multiscale data, which seems to be increasingly 
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Materials and Methods 
Participants 
Healthy subjects were recruited from the university environment and gave written informed 
consent to study procedures previously approved by the Ethics Committee of the University 
Medical Center Göttingen. Included participants were aged between 22 and 52 years (M = 
40.5, SD = 14.37), of Caucasian European ethnicity and were fluent in German language. 
Exclusion criteria comprised contraindications to MRI, past or present psychiatric, 
neurological, or medical disorders, consumption of psychotropic drugs as well as positive 
family history of psychiatric disorders. In total, a number of 26 men and 22 women completed 
two fMRI paradigms including reward processing and emotional face recognition. Excessive 
movement in any of the three translation (> 2 mm) or rotation (> 2°) planes resulted in 
exclusion of 4 participants. 
 
Functional brain imaging 
Functional imaging data was acquired using a 3 T scanner (Siemens Magnetom TRIO, 
Siemens Healthcare, Erlangen, Germany) and a 32-channel head coil with a 2 x 2 x 2 mm 
voxel size, TR 2500 ms, TE 33 ms, 70° flip angle, 10 % distance factor, FOV 256 mm and 60 
slices with multiband factor of 3 for the acquisition of T2*-weighted images. Imaging data 
analysis was performed using Statistical Parameter Mapping (SPM12; Wellcome Department 
of Imaging Neuroscience, Institute of Neurology, London, UK) and Matlab R2015b (The 
Mathworks Inc., Natick, MA, USA). First, echo planar imaging (EPI) images were standardly 
preprocessed with slice time correction, realignment, and normalization into the MNI space, 
as well as smoothing with an 8 x 8 x 8 mm FWHM Gaussian kernel. 
Two different fMRI paradigms were analyzed for the same group of participants during two 
states. First, specific activation maps reflected brain activation during performance of the 
tasks. In contrast, corresponding control conditions represented non-specific hemodynamic 
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activity inherent to any task performance during fMRI measurement, caused by unspecific 
physiological activation, e.g. related to visual, auditory, attentional or motor functions. 
Estimates of neural activity were initially computed with a general linear model (GLM) for 
each subject individually (first-level analysis) with nuisance movement parameters regressed 
as covariates-of-no-interest. Later, experimental and control conditions were evaluated in a 
group level (second-level analysis) and resulting data representing task-specific brain 
activation used for further analyses.  
 
Emotional face recognition 
The paradigm of implicit emotional face recognition contains two different contexts: human 
faces and geometric objects. Pictures of males and females with varying negative face 
expressions obtained from the Radboud database (32) were presented for 17 s, during which 
participants responded to the gender of the presented person with a button press. Thereby, 
perception of emotions was rather implicit, which has been shown to enhance the activation 
of emotional correlates (33). For the control condition, participants were instructed to respond 
analogously to the shape of an object, either an ellipse or a rectangle, positioned in the face 
area and made from scrambling original face trials. All trials were controlled for brightness, 
contrast and presented in a very similar composition. The activation patterns representing the 
experimental and control conditions were computed using first-level (single-subject) contrasts 
of the trials from emotional faces and object blocks respectively, which were then used for 
second-level (group) analysis, as standardly performed for random effects model.  
 
Reward processing 
For this study, a previously established fMRI paradigm was implemented, which has been 
broadly used to investigate physiological and pathological reward mechanisms (34). Briefly, 
participants performed a modified delayed match to sample task, including two contexts 
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involving previously conditioned stimuli to monetary rewards: acceptance or rejection of 
rewards, e.g. pressing a button when green squares are shown. Subjects were instructed they 
would receive 30 € for their participation, and that they were able to double this amount 
according to their task performance. As control trials, subjects responded with a button press 
e.g. to yellow squares as stimuli that required motor performance as well as attentional and 
memory resources but were not conditioned to monetary reward. To compute the control 
condition, first-level (single-subject) contrasts of correctly matched sample trials within the 
same experimental block of reward trials were used. For experimental conditions, first-level 
experimental contrasts were calculated from brain activation elicited during acceptance of 
previously conditioned stimuli. At group-level, activations related to experimental and control 
trials were contrasted to measure activation patterns, as standardly performed for random 
effects model.  
 
Meta-analytic functional brain activation 
Besides fMRI data obtained from participants performing two different tasks at our 
institution, we evaluated large-scale meta-analytical imaging data from the Neurosynth 
platform (https://neurosynth.org/), which provides probabilistic brain activity mappings 
computed from an automated synthesis of results from published fMRI studies. The online 
database combines text-mining and machine-learning techniques to generate meta-analyses of 
currently 1335 imaging terms from 14371 fMRI studies (13). For this study, Neurosynth 
activation maps related to emotional and reward fMRI data were downloaded in MNI152 2 
mm space to validate measured neuronal activation patterns obtained at our institution. 
To evaluate statistical overlap between meta-analytical terms and single-site fMRI activation 
maps, we correlated activation patterns of both datasets. As a first step, activation maps, with 
z-scores representing how brain regions are related to the chosen term, were generated from 
the Neurosynth online database. Since the online user interface only provides thresholded 
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maps, we used the Neurosynth toolbox for python to create unthresholded maps that were 
further smoothed using 8 x 8 x 8 mm FWHM to match the kernel size of single-site data. 
Subsequently, we assessed the association of meta-analytic data with measured fMRI maps by 
means of region-wise Spearman’s correlation coefficients in cortical and subcortical regions, 
whereby imaging paradigms related to recognition of negative faces and the acceptance of 
monetary rewards matched well with the Neurosynth terms “fearful faces” and “rewards”, 
respectively. Due to low fMRI activity, cerebellum was not considered for the comparison. 
Within the Neurosynth database, each term includes a uniformity test map that provides the 
degree to which each voxel is consistently activated in studies that use a given term. 
Secondly, an association test map is provided that controls for base rate activation differences 
between brain regions. Association test maps display specific regions, where functional 
activation related to a distinct term occur more consistently, compared to studies that don't 
mention that term. In contrast to single-site fMRI data, meta-analytical information comprises 
rather positive values, due to the sparse reporting of brain regions showing negative neuronal 
activation in most neuroimaging studies. Hence, when processing unthresholded data from the 
uniformity as well as association test maps, mainly positive values determined the association 
analysis between Neurosynth and measured fMRI maps.  
 
Whole brain gene expression 
The AHBA (www.brain-map.org) consists of microarray assessments from 3702 brain tissue 
samples collected across 6 human donors (1 female, mean age = 42.5, SD = 13.4) derived 
from diverse regions of the brain, extensively described in the original publication (29). As 
delineated by other authors (31), multiple data processing steps such as gene annotation, data 
filtering, probe selection or sample assignment need to be considered to facilitate subsequent 
correlation analyses between expression and neuroimaging data. Also, by using common 
parcellation schemes expression levels in numerous brain regions devoid of tissue samples 
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remain indefinite, thus demanding the generation of whole brain transcriptome maps. To 
sufficiently meet proposed methodological requirements, gene expression data (log2-values) 
from the AHBA were obtained according to Gryglewski et al. (28) to compensate for inter-
individual differences between mRNA probes and donor brains as well as sparse anatomical 
sampling, attributable to high efforts in tissue preparation and processing. Using Gaussian 
process regression, unbiased whole-brain transcriptome maps comprising expression of 
18,686 genes associated with Entrez Gene IDs at all cortical and subcortical structures were 
created (predicted transcriptome maps are available for download at 
www.meduniwien.ac.at/neuroimaging/mRNA.html). Nonetheless, for a certain number of 
remaining genes transcriptome maps have not been predicted sufficiently due to presence of 
insensitive probes or missing allocations to gene IDs.  
 
Spatial correlation between gene expression and brain activity 
Initially, gene lists ranking correlations between transcriptome maps and functional brain 
activation patterns elicited by selected paradigms were compiled, whereby the ranking of each 
gene depended on its correlation strength with the corresponding single-site BOLD activation 
map. After initial inspection, the cerebellum was excluded from further analysis, due to 
marginal activation during both fMRI paradigms. On the basis of marked differences in gene 
expression between broad anatomical regions (29) correlation analyses were assessed within 
cortical and subcortical regions separately. To conduct association analyses, all available 
transcriptome maps were aligned with group-averaged fMRI activation maps in MNI space 
for each paradigm. To account for partly non-symmetrical distribution of mRNA data and 
existence of outliers, Spearman’s correlation coefficients were calculated between each gene-
imaging pair (mRNA expression vs. fMRI activation). Main findings are reported for region-
wise analyses, along with additional results for voxel-wise correlations (total number of 
voxels was 129,817 in the cortex and 10,863 in subcortex; zero-values outside of the 
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investigated area were excluded). Thereby, each statistical map was segmented into brain 
regions according to the Brainnetome atlas, which was selected for primary analyses, because 
it labels a sufficient number of subcortical (n = 36) and cortical (n = 210) regions-of-interest 
(ROIs) (35). A complementary analysis with fewer brain regions (12 subcortical and 78 
cortical ROIs) was done using the automated anatomical labeling (AAL) brain atlas (36), in 
order to evaluate influences of different parcellation methods. Both atlases were aligned with 
fMRI maps as well as transcriptome maps in MNI space using SPM12, while extraction of 
ROIs and correlation analyses were performed in MATLAB2018a (www.mathworks.com). 
Statistical significances of region-wise correlations were assessed by means of randomization 
tests, including 10,000 iterations. For each sampled permutation, mRNA values were 
randomly shuffled and correlated with fMRI data. Two-sided p-values were calculated as the 
proportion of sampled permutations where the absolute value was greater than the true 
correlation coefficient (non-shuffled data). 
 
Identification of overlap between analyzed data set 
To compare various sets of mRNA-fMRI correlations we used Rank-Rank Hypergeometric 
Overlap (RRHO) package (version 1.26.0) in R 
(https://www.bioconductor.org/packages/release/bioc/html/RRHO.html), which allows 
statistical testing of the extent of overlap between two ranked lists. RRHO determines the 
degree of differential expression observed in profiling experiments using the hypergeometric 
distribution. While originally applied for the comparison of gene expression profiles between 
different microarray platforms or types of model system, we used RRHO to compare genes 
that ranked according to relevant measures of differential information, in this case the 
correlation strength with fMRI data. Thereby, genes of two datasets were ranked according to 
their names and corresponding ranks tested for statistical overlap. We provide both a 
graphical representation of the characteristics of analyzed datasets (corresponding p-values) 
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as well as a statistical measure of overlap (rhoRRHO). A high overlap implies that positively 
correlating genes of a given list show high ranks in the second list, while genes with a 
negative correlation are also negatively associated in the alternative list. Applying this method 
offered the advantage of using the whole continuum of previously correlated genes without 
the need to truncate the list by pre-defined thresholds for each combination of used datasets.  
 
Analysis of biological processes 
Making use of the GO knowledgebase (12), a comprehensive resource for computational 
analysis of large-scale data, we explored enriched biological processes that included genes 
with expression patterns highly correlated with each fMRI paradigm. Cytoscape plugin 
“ClueGO” (37) was used to compute GO enrichment (default parameters), comprising all 
listed terms at the time of analysis (18,361 biological process terms). Only findings of 
specialized biological processes (GO levels higher than 4) were reported, to attain more 
conclusive information about underlying genetic substrates and their functions within 
investigated emotion and reward systems. Compiled ranked lists originating from region-wise 
analyses were included for the investigation of gene ontology, due to more refined results. For 
each paradigm, the GO analysis was performed separately for positively and negatively 
correlated genes with cut-off values for correlation coefficients above rho = 0.5 and below rho 
= -0.5, which excluded non-spatially depending genes showing insufficient associations with 
fMRI data. Significance level was set to a p-value minimum of 0.05, after applying 
Bonferroni correction to the enriched GO terms. Considering potential overlaps across 
imaging paradigms, interrelations between all significant biological processes found in the 
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Association of risk genes for major depression with functional imaging data 
Topological expression patterns of genes associated with major depression and their 
association with neuroimaging parameters have not yet been investigated. Regarding genetic 
risks for depressive disorders, recently 44 genetic risk loci for major depression were 
identified in a genome-wide association meta-analysis by Wray et al., which included 135,458 
cases and 344,901 controls (9). Based on this meta-analysis, we investigated if the MDD risk 
gene set contained MRs of previously compiled genes showing strong correlations between 
gene expression and imaging data. Thereby, the role of all 42 functional risk genes proposed 
by Wray et al. was evaluated for each fMRI paradigm (table S4). 
By using the cytoscape plugin iRegulon (38), we performed master regulator analysis 
separately for all positive and negative mRNA-fMRI correlations above rho = 0.6 and below 
rho = -0.6, respectively. Rather low thresholds were set to ensure a sufficient number of 
evaluated genes in subcortical regions. In the cortex, insufficient data availability hampered 
analyses of co-regulatory networks, due to generally lower correlation coefficients of mRNA-
fMRI associations compared to the subcortex. Parameters, such as enrichment score and 
significances, were used as default; distance from TSS was set to 500bp. We compared the 
master regulators on each predicted regulon with the genes associated with risk for major 
depression. 
Further, correlations between fMRI data and reported risk genes for MDD were compared 
with all remaining genes by means of GSEA (39), to assess clustering of risk genes for each 
fMRI paradigm. Regarding applied methodology of GSEA, enrichment score reflects the 
degree to which the analyzed MDD risk gene set is overrepresented within each ranked list. 
Thereby, we evaluated whether MDD risk genes were randomly distributed throughout each 
ranked list or primarily found at the top (showing positive correlations with fMRI data) or 
bottom (showing negative correlations). We used the GSEA implementation in R available in 
the package clusterProfiler (40). For quantification, the ES was calculated by a stepwise 
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increase or decrease of the total sum statistic of the ranked list, depending on the ranking of 
MDD risk genes, as described by Subramanian et al. (39). Thereby, the ES, corresponding to 
a weighted Kolmogorov-Smirnov-like statistic, represents the maximum deviation from zero 
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Fig. S1. Rank–rank hypergeometric overlap (RRHO) visual representation of measured 
imaging data for reward vs. emotion processing. 
Fig. S2. Voxel-wise vs. region-wise correlation analyses of single-site imaging data during 
emotion processing. 
Fig. S3. Voxel-wise vs. region-wise correlation analyses for single-site imaging data during 
reward processing. 
Fig. S4. Comparison of functional brain activation during reward processing and mRNA 
expression of DUSP3 in cortical regions. 
Fig. S5. Enriched biological programs for emotion and reward processing based on 
ontological structure. 
Fig. S6. Gene Set Enrichment Analysis (GSEA) for emotion and reward processing, including 
risk genes associated with major depression. 
Table S1. Regions showing functional brain activation during emotional face recognition and 
acceptance of monetary rewards.  
Table S2. Associations between functional imaging and transcriptome data. 
Table S3. Enriched biological programs for emotion and reward processing based on 
ontological structure. 
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Fig. 1. Rank–rank hypergeometric overlap (RRHO) visual representation of measured 
imaging data applying automated anatomical labeling (AAL) vs. the Brainnetome atlas. 
Analyzing single-site data, region-wise RRHO comparing ranked lists including 18,686 genes 
indicated high agreement between the atlases. Genes with congruent correlation coefficients 
(either positive or negative) show higher statistical significance in the bottom left and top 
right corner. Comparisons of both parcellation methods were performed for emotional face 
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recognition in the subcortex (rhoRRHO = 0.697) and cortex (rhoRRHO = 0.822), as well as for 
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Fig. 2. Comparison of task-specific functional brain activation and mRNA expression of high-
correlating genes in cortical and subcortical regions. (A) The scatter plots depict correlations 
between cortical mRNA levels of FOXN4 and single-site imaging data (emotional face 
recognition) for voxel-wise (rho = 0.285; 129,817 voxels) and region-wise (rho = 0.431; 210 
regions, p < 0.0001) analyses. Each dot represents expression values and corresponding 
imaging parameters at target coordinates or within anatomical regions, respectively. (B) 
Cortical FOXN4 gene expression and brain activation patterns during emotion processing are 
visualized in MNI space based on whole-brain transcriptome maps (log2) and functional 
magnetic resonance imaging data (t-value). (C) Associations between subcortical mRNA 
levels of MDK and single-site imaging data (acceptance of monetary rewards) for voxel-wise 
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(rho = 0.488; 10,863 voxels) and region-wise (rho = 0.803; 36 regions, p < 0.0001) analyses. 
(D) Subcortical MDK gene expression (log2) and brain activation patterns during reward 
processing (t-value).  
 
 
Fig. 3. Heatmap depicting interrelations of associated biological processes listed within the 
gene ontology (GO) knowledgebase for emotion and reward processing. Overall, 5 (emotion, 
positive), 78 (reward, negative), and 27 (reward, positive) GO terms that overlapped with 
genes strongly correlated with single-site imaging data were compared in subcortical regions 
(GO terms of analyzed biological programs are provided in supplementary table 3). Results 
yielded marked redundancies for both paradigms (emotional face recognition: blue; 
acceptance of monetary rewards: red). Considering the multitude of possible associations of 
18,686 genes with all listed GO terms, analyses were restricted to higher ontological 
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hierarchies (GO levels above 4). Further, only reasonable correlations between imaging and 
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Fig. 4. Relationship between risk genes for depressive disorders and genes correlated with 
functional brain imaging. (A) Two master regulators associated with depressive disorders and 
corresponding subordinate genes correlated with emotion and reward processing present in 
single-site and meta-analytical data sets are presented. Graphical visualizations are based on 
associations between gene expression and single-site imaging data in subcortical regions (p < 
0.001). The size of each circle corresponds to the absolute value of Spearman’s correlation 
coefficient of the respective gene. MEF2C mainly regulates genes with expression patterns 
negatively correlated with emotion (16 targets, blue) and reward processing (51 targets, red). 
(A) In contrast, TCF4 inversely regulates genes showing negative associations with emotion 
(15 targets), but positive associations with reward processing (67 targets). (C) Gene set 
enrichment analysis revealed an inversed relationship between emotion and reward processing 
in the subcortex. Vertical lines on the x-axis represent positions of 42 functional risk genes 
within each ranked list including 18,686 genes, dashed lines mark the locations of the 
maximum enrichment score (ES) which draws a density line depicting the peak enrichment of 
risk genes. Analyzing data from the Neurosynth framework, ES yielded a positive value for 
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Table 1. Ranking of Spearman’s correlation coefficients for genes with expression patterns 
showing highest positive associations with single-site imaging data (emotional face 
recognition).  
Subcortex Cortex 
Voxel-wise correlations Region-wise correlations Voxel-wise correlations Region-wise correlations 
rho Gene name rho Gene name rho Gene name rho Gene name 
0.633 MALL 0.865 C10orf125 0.328 SPDYA 0.431 FOXN4 
0.616 HRASLS5 0.845 PTRH1 0.298 CCDC62 0.395 PIK3R6 
0.614 FAT4 0.818 GHRLOS 0.296 PYGO2 0.390 RYBP 
0.612 SCARA5 0.817 SLC24A4 0.289 CPZ 0.387 STC1 
0.610 MESP1 0.817 AC022098.3 0.285 FOXN4 0.384 CCDC62 
0.608 LINC00260 0.812 ZNF280C 0.283 FRMD3 0.379 FUBP1 
0.604 SKAP2 0.810 FUT1 0.282 PHOX2B 0.378 SMYD1 
0.602 SCPEP1 0.804 NLE1 0.280 ATXN10 0.356 MIA2 
0.596 CRHBP 0.803 FBP1 0.276 XAGE3 0.356 TMPRSS4 
0.594 RAB3GAP1 0.803 C16orf55 0.273 EGFL6 0.350 DLG3 
Footnote: Bold names correspond to genes that were ranked within the 10 highest positive 
correlating genes both for voxel-wise and region-wise analyses. All listed region-wise 
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Table 2. Ranking of Spearman’s correlation coefficients for genes with expression patterns 
showing highest positive associations with single-site imaging data (acceptance of monetary 
rewards).  
Subcortex Cortex 
Voxel-wise correlations Region-wise correlations Voxel-wise correlations Region-wise correlations 
rho Gene name rho Gene name rho Gene name rho Gene name 
0.488 MDK 0.810 VMO1 0.548 DUSP3 0.698 DUSP3 
0.481 HELLS 0.805 OSTM1 0.547 CA10 0.681 CA10 
0.475 RBBP8 0.803 MDK 0.542 PIK3CD 0.680 PIK3CD 
0.453 ATF1 0.798 KRT18P19 0.533 GRB14 0.653 HDAC9 
0.451 KRT18P19 0.791 IMPACT 0.517 ASS1 0.640 LASS6 
0.450 CD274 0.787 USP24 0.516 LASS6 0.639 CCNYL1 
0.446 C8orf22 0.784 NEK1 0.505 HDAC9 0.637 GRB14 
0.442 SALL4 0.782 RCBTB2 0.504 FBXL2 0.627 OLFM3 
0.440 USP24 0.782 PCBD2 0.497 OLFM3 0.609 SHC1 
0.439 SFRP5 0.781 CD99 0.492 TMEM150C 0.607 NT5DC2 
Footnote: Bold names correspond to genes that were ranked within the 10 highest positive 
correlating genes both for voxel-wise and region-wise analyses. All listed region-wise 
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Table 3. Master regulator analysis in subcortical regions for emotion and reward processing. 
 Emotional face recognition Acceptance of monetary rewards 























--- MEF2C (21/348) 
 
TCF4 (87/208) 
Footnote: Master regulators were evaluated in single-site as well as meta-analytical imaging 
datasets by means of co-regulatory networks built with iRegulon software (p < 0.001). 
Ranked genes that showed highest correlation with brain activation maps and 42 functional 
risk genes associated with major depression were used as input data. Values in parenthesis 
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